Recurrent Ph-Like Acute Lymphoblastic Leukemia Active Not Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0120008 (Recurrent Ph-Like Acute Lymphoblastic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs